Valuation: Divi's Laboratories Limited

Market Cap 1,924B 19.98B 17.55B 16.32B 14.98B 28.14B 28.57B 194B 75.72B 946B 75.01B 73.39B 3,271B P/E 2027 *
64.3x
P/E 2028 * 52.6x
Enterprise Value 1,891B 19.63B 17.24B 16.04B 14.72B 27.65B 28.08B 190B 74.4B 930B 73.71B 72.12B 3,214B EV / Sales 2027 *
15.4x
EV / Sales 2028 * 13x
Free-Float
48%
Yield 2027 *
0.49%
Yield 2028 * 0.55%
1 day-0.77%
1 week+0.01%
Current month+10.18%
1 month+7.97%
3 months+13.94%
6 months+20.58%
Current year+13.39%
1 week 7,177
Extreme 7177
7,438.5
1 month 6,530.5
Extreme 6530.5
7,438.5
Current year 5,647.5
Extreme 5647.5
7,438.5
1 year 5,636.5
Extreme 5636.5
7,438.5
3 years 3,295.3
Extreme 3295.3
7,438.5
5 years 2,730
Extreme 2730
7,438.5
10 years 532.65
Extreme 532.65
7,438.5
Manager TitleAgeSince
Chief Executive Officer 75 25/11/2009
Chief Executive Officer 48 03/01/2020
Director of Finance/CFO 65 31/07/2025
Director TitleAgeSince
Director/Board Member 48 25/11/2009
Chairman 75 25/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.77%+0.01%+9.55%+94.88% 19.98B
+0.86%+1.43%+47.17%+161.40% 1,067B
+1.59%+4.09%+56.51%+52.79% 635B
+0.95%+1.91%+36.30%+83.13% 458B
+1.60%+6.25%+37.00%+30.00% 347B
-0.60%+1.52%+36.67%+39.80% 295B
-0.14%+0.60%+17.29%+18.19% 262B
+0.09%-2.82%-29.09%-41.29% 216B
+1.22%+2.66%+22.66%+59.81% 203B
-1.18%-3.70%+11.28%+67.43% 161B
Average +0.36%+1.19%+24.53%+56.62% 366.35B
Weighted average by Cap. +0.75%+1.94%+35.85%+78.24%

Financials

2027 *2028 *
Net sales 123B 1.27B 1.12B 1.04B 953M 1.79B 1.82B 12.34B 4.82B 60.23B 4.78B 4.67B 208B 145B 1.51B 1.32B 1.23B 1.13B 2.12B 2.15B 14.6B 5.7B 71.27B 5.65B 5.53B 246B
Net income 30.25B 314M 276M 257M 235M 442M 449M 3.05B 1.19B 14.87B 1.18B 1.15B 51.42B 37.04B 385M 338M 314M 288M 542M 550M 3.73B 1.46B 18.21B 1.44B 1.41B 62.96B
Net Debt -33.46B -347M -305M -284M -260M -489M -497M -3.37B -1.32B -16.45B -1.3B -1.28B -56.88B -41.92B -435M -382M -356M -326M -613M -623M -4.22B -1.65B -20.61B -1.63B -1.6B -71.26B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
24/07/26 ₹7,248.50 -0.77% 328,948
23/07/26 ₹7,305.00 -1.10% 246,545
22/07/26 ₹7,386.50 +0.77% 371,324
21/07/26 ₹7,330.00 +0.16% 179,558
20/07/26 ₹7,318.00 +0.97% 434,480
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
7,248.50INR
Average target price
7,088.80INR
Spread / Average Target
-2.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock